Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ARQT compared with PVLA: revenue, margins and what each company keeps, and the suppliers and customers both name
ARQT
Arcutis Biotherapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
PVLA
Palvella Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
ARQT
Arcutis Biotherapeutics, Inc.
vs
PVLA
Palvella Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
Co-movers
daily closes · 460d
Method
›
Moved together
ARQT
with
PVLA
×0.41
co-movement · PVLA on ARQT · 460d
r 0.31
scale to r 0.75
Shared co-movers
4
with ARQT
with PVLA
BEAM
Beam Therapeutics Inc.
r 0.38
r 0.37
NRIX
Nurix Therapeutics, Inc.
r 0.38
r 0.33
XNCR
Xencor Inc
r 0.40
r 0.32
INDV
Indivior Pharmaceuticals, Inc.
r 0.53
r 0.32
ARQT, solid
PVLA, hatched
× = co-movement · β
r = correlation
Bar = r to r 0.75
Order: weaker of A and B
Source: daily closes
ARQT
Arcutis Biotherapeutics, Inc.
Change
31.73
▼
−1.07%
Mkt cap
$4.0B
Revenue
$130M
Q2 FY26
Revenue
$376M
FY25
PVLA
Palvella Therapeutics, Inc.
Change
146.36
▲
+0.15%
Regular session
Nov 2 '26
Mkt cap
—
Revenue
—
Revenue
—
vs
Compare
Regular session
Nov 2 '26
ARQT
Arcutis Biotherapeutics, Inc.
vs
PVLA
Palvella Therapeutics, Inc.
31.73
▼
−1.07%
Price
146.36
▲
+0.15%
$4.0B
Mkt cap
—
Q2 FY26
$130M
Revenue
—
FY25
$376M
Revenue
—
Change
Change
ARQT
31.73
▼
−1.07%
vs
PVLA
146.36
▲
+0.15%
Regular session
Nov 2 '26